文献速递神经儿科影像MR

采用波控并行成像加速的非增强3D T1-MPRAGE用于婴儿脑成像

Accelerated Nonenhanced 3D T1-MPRAGE Using Wave-Controlled Aliasing in Parallel Imaging for Infant Brain Imaging.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-10-20

回顾性评估68例婴儿(平均年龄1.78个月)的非增强标准与波控并行成像加速MPRAGE(wave-T1-MPRAGE)序列,比较图像质量、伪影、髓鞘化程度、解剖结构显示及非强化病灶诊断效能。wave-T1-MPRAGE整体图像质量及解剖显示评分低于标准MPRAGE,但运动伪影与髓鞘化程度无显著差异,非强化病灶诊断效能相当,仅漏诊2个微小病灶。

要点

  • wave-T1-MPRAGE整体图像质量与解剖显示评分低于标准MPRAGE,但运动伪影与髓鞘化程度无显著差异。
  • wave-T1-MPRAGE对非强化脑实质病灶的诊断效能与标准MPRAGE相当,仅漏诊2个微小病灶。
  • wave-T1-MPRAGE可显著缩短扫描时间,可作为婴儿颅内病变诊断的替代方案。

核心结论

  • wave-T1-MPRAGE整体图像质量低于标准MPRAGE,但对非强化脑实质病灶的诊断效能相当,且扫描时间显著缩短,可能作为婴儿颅内病变诊断的替代方案。

研究设计与样本

  • 回顾性评估68例婴儿(平均年龄1.78个月,标准差1.70个月),均接受非增强标准与wave-T1-MPRAGE序列;由两名神经放射科医生独立采用4点Likert量表评估图像质量、伪影、髓鞘化程度及解剖结构显示,并判断脑实质内非强化病灶是否存在。

关键影像表现/征象

  • wave-T1-MPRAGE整体图像质量与解剖结构显示的平均评分及观察者间一致性均低于标准MPRAGE(P均<0.001)。
  • 两种MPRAGE序列在运动伪影(观察者1 P=0.90,观察者2 P=0.14)和髓鞘化程度(观察者1 P=0.16,观察者2 P=0.32)上无显著差异。
  • 标准MPRAGE上两名观察者均可见的非强化病理病灶中,wave-T1-MPRAGE仅漏诊2个,为非常微小、模糊、非出血性白质损伤。

诊断标准与关键数值

  • 采用4点Likert量表评估图像质量、伪影、髓鞘化程度及解剖结构显示。
  • wave-T1-MPRAGE整体图像质量与解剖显示评分显著低于标准MPRAGE(P<0.001)。
  • 运动伪影与髓鞘化程度在两种序列间无显著差异(运动伪影P=0.90/0.14,髓鞘化P=0.16/0.32)。

临床应用与阅片要点

  • wave-T1-MPRAGE可显著缩短扫描时间,可能作为婴儿颅内病变诊断的替代方案。
  • wave-T1-MPRAGE整体图像质量与解剖显示低于标准MPRAGE,阅片时需注意。
  • wave-T1-MPRAGE可能漏诊非常微小、模糊、非出血性白质损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: MPRAGE is the most commonly used sequence for high-resolution 3D T1-weighted imaging in pediatric patients. However, its longer scan time is a major drawback because pediatric patients are prone to motion and frequently require sedation. This study compared nonenhanced accelerated MPRAGE using wave-controlled aliasing in parallel imaging (wave-T1-MPRAGE) with standard MPRAGE in infants.

MATERIALS AND METHODS: We retrospectively evaluated 68 infants (mean age, 1.78 [SD. 1.70] months) who underwent nonenhanced standard and wave-T1-MPRAGE. Two neuroradiologists independently assessed each image for image quality, artifacts, myelination degree, and anatomic delineation using the 4-point Likert scale. For diagnostic performance, both observers determined whether nonenhancing lesions were present in the brain parenchyma in 2 types of nonenhanced MPRAGE sequences.

RESULTS: Wave-T1-MPRAGE showed a significantly lower mean score and lower interobserver agreement for overall image quality and anatomic delineation than standard MPRAGE (P< .001 for each). However, there were no significant differences between the 2 types of MPRAGE sequences for motion artifacts (P = .90 for observer 1, P = .14 for observer 2) and degree of myelination (P = .16 for observer 1, P = .32 for observer 2). Among the nonenhancing pathologic lesions observed on standard MPRAGE by both observers, only 2 were missed on wave-T1-MPRAGE, and they were very tiny, faint, nonhemorrhagic WM injuries.

CONCLUSIONS: Although wave-T1-MPRAGE showed lower overall image quality than standard MPRAGE, the diagnostic performance for nonenhancing parenchymal lesions was comparable. Wave-T1-MPRAGE could be an alternative for diagnosing intracranial lesions in infants, with marked scan time reduction.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Yun SY, Heo YJ. Accelerated Nonenhanced 3D T1-MPRAGE Using Wave-Controlled Aliasing in Parallel Imaging for Infant Brain Imaging. AJNR Am J Neuroradiol. 2022. PMID: 36265893. doi:10.3174/ajnr.A7680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。